completely new strength [Regulatives / Guidelines]

posted by Clarc Homepage – Romania, 2013-10-21 10:01 (4629 d 01:31 ago) – Posting: # 11713
Views: 4,164

Thank You ElMaestro

❝ If you target USA then it will be a 505(b)(2) and if you are targeting EU then it will be a 10.3. Not generic. If the claim is to make the drug 'more effective' then BE or TE is not the aim of the pivotal trial - you will be looking at superiority.


The sponsor only say that it is more effective using this strength, but does not want to prove it, so the claim is not to make the drug more effective, but to have a different strength on the market.
However You were right about the 10.3., this is the way they should go with it.

Thanks again.

Clarc :-)

I'm always tryin' to do something new, tryin' to look like a beginner.
Meshell Ndegeocello

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
162 visitors (0 registered, 162 guests [including 16 identified bots]).
Forum time: 11:33 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5